4/26
10:45 am
bgne
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report [Yahoo! Finance]
Low
Report
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report [Yahoo! Finance]
4/26
10:34 am
bgne
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
Low
Report
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
4/24
04:14 pm
bgne
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting [Yahoo! Finance]
Medium
Report
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting [Yahoo! Finance]
4/24
04:01 pm
bgne
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
Medium
Report
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
4/24
01:38 pm
bgne
BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $235.00 to $236.00. They now have a "buy" rating on the stock.
Low
Report
BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $235.00 to $236.00. They now have a "buy" rating on the stock.
4/23
10:19 am
bgne
With 42% ownership of the shares, BeiGene, Ltd. (NASDAQ:BGNE) is heavily dominated by institutional owners [Yahoo! Finance]
Low
Report
With 42% ownership of the shares, BeiGene, Ltd. (NASDAQ:BGNE) is heavily dominated by institutional owners [Yahoo! Finance]
4/23
06:10 am
bgne
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer [Yahoo! Finance]
Medium
Report
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer [Yahoo! Finance]
4/23
06:00 am
bgne
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Medium
Report
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
2/26/2024
06:00 am
BGNE
beigene, ltd. - american depositary shares
BEAT
Report
2.0%
beigene, ltd. - american depositary shares
11/9/2023
04:01 pm
BGNE
beigene, ltd. - american depositary shares
BEAT
Report
5.0%
beigene, ltd. - american depositary shares
8/2/2023
06:00 am
BGNE
beigene, ltd. - american depositary shares
MISS
Report
-8.8%
beigene, ltd. - american depositary shares
5/4/2023
07:00 am
BGNE
beigene, ltd. - american depositary shares
BEAT
Report
-1.7%
beigene, ltd. - american depositary shares
4/26
04:23 pm
bgne
Form ARS BeiGene, Ltd. For: Dec 31
Neutral
Report
Form ARS BeiGene, Ltd. For: Dec 31
4/26
04:17 pm
bgne
Form DEF 14A BeiGene, Ltd. For: Jun 05
Neutral
Report
Form DEF 14A BeiGene, Ltd. For: Jun 05
4/26
07:16 am
bgne
Form 8-K BeiGene, Ltd. For: Apr 26
Low
Report
Form 8-K BeiGene, Ltd. For: Apr 26
4/23
04:14 pm
bgne
Form 8-K BeiGene, Ltd. For: Apr 23
Medium
Report
Form 8-K BeiGene, Ltd. For: Apr 23
4/15
04:28 pm
bgne
Form PRE 14A BeiGene, Ltd. For: Jun 05
Low
Report
Form PRE 14A BeiGene, Ltd. For: Jun 05
4/11
06:02 pm
bgne
Form 4 BeiGene, Ltd. For: Apr 09 Filed by: OYLER JOHN
Low
Report
Form 4 BeiGene, Ltd. For: Apr 09 Filed by: OYLER JOHN
4/9
04:22 pm
bgne
Form 144 BeiGene, Ltd. Filed by: OYLER JOHN
Low
Report
Form 144 BeiGene, Ltd. Filed by: OYLER JOHN
3/26
05:27 pm
bgne
Form 3 BeiGene, Ltd. For: Mar 19 Filed by: Ball Titus B.
Medium
Report
Form 3 BeiGene, Ltd. For: Mar 19 Filed by: Ball Titus B.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register